These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29427173)

  • 1. Guest editorial: advances in immunotherapy for hematological malignancies.
    Kadowaki N
    Int J Hematol; 2018 Mar; 107(3):260-261. PubMed ID: 29427173
    [No Abstract]   [Full Text] [Related]  

  • 2. [NKT cell-mediated immunotherapy for hematological malignancies].
    Fujii S
    Rinsho Ketsueki; 2007 Mar; 48(3):188-99. PubMed ID: 17441475
    [No Abstract]   [Full Text] [Related]  

  • 3. [WT1 peptide-based immunotherapy for the treatment of malignancies: focusing on hematological neoplasms].
    Oka Y; Tsuboi A; Nishida S; Hosen N; Nakata J; Hashii Y; Maeda T; Oji Y; Kumanogoh A; Sugiyama H
    Rinsho Ketsueki; 2011 May; 52(5):235-42. PubMed ID: 21646768
    [No Abstract]   [Full Text] [Related]  

  • 4. The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective.
    Baron F; Storb R
    Best Pract Res Clin Haematol; 2006; 19(4):637-53. PubMed ID: 16997174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guest editorial: Immunotherapy for hematological malignancies: the quest to overcome tolerogenic drive.
    Kadowaki N
    Int J Hematol; 2014 Feb; 99(2):105-6. PubMed ID: 24395282
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell modulation in immunotherapy for hematological malignancies.
    Lin C; Chen S; Li Y
    Cell Biol Toxicol; 2017 Aug; 33(4):323-327. PubMed ID: 28474249
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular immunotherapy for hematological malignancies].
    Yasukawa M
    Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy in hematological malignancies: recent advances and open questions.
    Tawfik EA; Aldrak NA; Albrahim SH; Alzahrani DA; Alfassam HA; Alkoblan SM; Almalik AM; Chen KS; Abou-Khalil R; Shah K; Zaidan NM
    Immunotherapy; 2021 Oct; 13(14):1215-1229. PubMed ID: 34498496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New immunotherapy-based approach in allogeneic hematopoietic stem cell transplantation.
    Maeda Y
    Int J Hematol; 2018 Feb; 107(2):129. PubMed ID: 29260506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hematologic malignancies/pediatric malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2009 May; 36(5):742-3. PubMed ID: 19496282
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy for Hematologic Malignancies.
    Craddock C; Friedberg JW
    J Clin Oncol; 2021 Feb; 39(5):343-345. PubMed ID: 33434044
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of hematological malignancies: what is new?
    Ortín M
    Ann Oncol; 2005; 16 Suppl 2():ii53-62. PubMed ID: 15958476
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of hematologic malignancies: the road to the future.
    Sotomayor EM; Loughran TP
    Cancer Control; 2002; 9(2):97-8. PubMed ID: 11965230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in Immunotherapy for Hematological Malignancies].
    Yasukawa M
    Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):1061-8. PubMed ID: 30168700
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
    Rukavitsyn OA
    Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody-directed therapies for hematological malignancies.
    Linenberger ML; Maloney DG; Bernstein ID
    Trends Mol Med; 2002 Feb; 8(2):69-76. PubMed ID: 11815272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hematological malignancy-associated antigens and clinical applications.
    Fujiwara H
    Rinsho Ketsueki; 2009 May; 50(5):340-51. PubMed ID: 19483393
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy of hematological malignancies using dendritic cells.
    Van de Velde AL; Berneman ZN; Van Tendeloo VF
    Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards immunogene therapy of hematological malignancies.
    Ivanov R; Hagenbeek A; Ebeling S
    Exp Hematol; 2006 Mar; 34(3):251-63. PubMed ID: 16543059
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in T-cell immunotherapy for haematological malignancies.
    Rouce RH; Sharma S; Huynh M; Heslop HE
    Br J Haematol; 2017 Mar; 176(5):688-704. PubMed ID: 27897332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.